
    
      PRIMARY OBJECTIVE Evaluate the Improvement of Nonmotor symptom scale (NMSS) between
      Pramipexole and Bromocriptine for early Parkinson's disease during 24-week treatment

      SECONDARY OBJECTIVE

        -  Evaluate the improvement for Depression which is one of the Nonmotor symptoms

        -  Evaluate the improvement of clinical symptoms between two groups

        -  Evaluate the improvement of Quality of Life between two groups
    
  